These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4806444)

  • 1. [Effect of short-term treatment with chlorophenoxyisobutyrate on serum lipids and pseudocholinesterase and plasmatic fibrinogen in hyperlipemic patients].
    Hărăguş S; Uza G; Opincaru A; Cucuianu M
    Stud Cercet Med Interna; 1973; 14(1):33-9. PubMed ID: 4806444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyperlipemic conditions: results of their treatment with clofibrate-methandrostenolone].
    Ciammaichella A; Torcia L
    Boll Soc Ital Cardiol; 1971; 16(12):841-51. PubMed ID: 5150179
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
    Malhotra SC; Ahuja MM
    Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia.
    Arora RC; Arora S
    Atherosclerosis; 1981 Jul; 39(4):447-52. PubMed ID: 7259824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia].
    Cagánová A; Cagán S
    Bratisl Lek Listy; 1972 Jul; 58(1):66-78. PubMed ID: 5077942
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum pseudocholinesterase activity during experimental fattening.
    Popescu TA; Fekete T; Popescu E; Böjthy I; Laszlo M
    Med Interne; 1976; 14(1):71-3. PubMed ID: 946698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum pseudocholinesterase activity in acute myocardial infarction.
    Vachharajani SD; Grover DN
    Indian Heart J; 1976 Jan; 28(1):29-32. PubMed ID: 1032885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum pseudocholinesterase activity during intravenous procaine anesthesia].
    Shi WZ
    Zhonghua Wai Ke Za Zhi; 1983 Nov; 21(11):670-5. PubMed ID: 6676013
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
    Gniwotta E; Herter B
    ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum pseudocholinesterase in state anxiety.
    Modai I; Mendelsohn E; Schwartz B
    J Clin Psychiatry; 1987 May; 48(5):204-6. PubMed ID: 3571175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of serum pseudocholinesterase and transferrin in intensive care patients].
    Cantoni A; Pizzola A
    Minerva Anestesiol; 1986; 52(1-2):51-7. PubMed ID: 3736913
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum pseudocholinesterase in acute myocardial infarction.
    Sharma SC; Seth HN
    Indian J Pathol Microbiol; 1978 Jan; 21(1):69-72. PubMed ID: 721218
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of tobramycin on serum pseudocholinesterase levels.
    Paradelis AG; Balamoutsos NG; Anastassiadou G; Veggou H
    Methods Find Exp Clin Pharmacol; 1982; 4(2):121-3. PubMed ID: 7121122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pseudocholinesterase estimation in the management of organophosphate poisoning cases and the effect of PAM on regenerating it.
    Saravanapavananthan T
    Singapore Med J; 1987 Apr; 28(2):166-71. PubMed ID: 3629272
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum pseudocholinesterase levels in the patients of coronary artery disease & their 'normal' first degree relatives.
    Tripathi AK; Sikka KK; Srivastava DK
    Indian Heart J; 1987; 39(1):9-11. PubMed ID: 3450576
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum pseudocholinesterase levels in anaesthesiologists and radiologists.
    Balamoutsos NG; Pantazopoulou T; Anissoglou G; Zachariades B; Veggou H; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983 Jun; 5(5):335-40. PubMed ID: 6621179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Trans Am Clin Climatol Assoc; 1968; 79():216-28. PubMed ID: 5760587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.